RCHY1 and Miyoshi myopathy: Thus, it was established that the decreased level of Pirh2 not only associated with MM resistance to bortezomib, but also that high Pirh2 expression was observed more often in patients with newly diagnosed MM than in patients with relapsed MM [190].